Insmed

Quickly Approaching Biopharma Catalyst Events

Quickly Approaching Biopharma Catalyst Events

Seeking Alpha

Orphan Status for Insmed's Arikace

Orphan Status for Insmed's Arikace

Yahoo/Zacks

Insmed Earnings: An Early Look

Insmed Earnings: An Early Look

Motley Fool

Vivus Announces Suit Dismissal and 4 Healthcare Stocks in Demand

Vivus Announces Suit Dismissal and 4 Healthcare Stocks in Demand

Wall Street Cheat Street

Insmed Ignites Higher and 4 Healthcare Stocks to Analyze Now

Insmed Ignites Higher and 4 Healthcare Stocks to Analyze Now

Wall Street Cheat Street

Insmed Earnings: Transition is the Key Word, and Investors Don’t Like It

Insmed Earnings: Transition is the Key Word, and Investors Don’t Like It

Wall St. Cheat Sheet

Insmed Inc. Earnings: Loss Narrows and Tops Forecasts

Insmed Inc. Earnings: Loss Narrows and Tops Forecasts

Wall St. Cheat Sheet

FDA lifts hold on trials of Insmed lung drug, shares up

FDA lifts hold on trials of Insmed lung drug, shares up

Reuters

Insmed shares spike after FDA lifts hold

Insmed shares spike after FDA lifts hold

Fierce Biotech

FDA lifts hold on Insmed's lung disease drug

FDA lifts hold on Insmed's lung disease drug

Reuters